华东医药
(000963)
| 流通市值：457.54亿 | | | 总市值：457.73亿 |
| 流通股本：17.53亿 | | | 总股本：17.54亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 5,605,360,468.39 | 3,734,865,777.19 | 4,978,052,188.84 | 4,375,309,533.55 |
| 应收票据及应收账款 | 8,850,825,667.24 | 11,076,591,135.34 | 8,991,801,339.36 | 11,136,300,073.66 |
| 其中：应收票据 | 9,420,826.08 | - | 6,213,394.05 | 5,630,773.62 |
| 应收账款 | 8,841,404,841.16 | 11,076,591,135.34 | 8,985,587,945.31 | 11,130,669,300.04 |
| 应收款项融资 | 865,267,156.65 | 332,387,014.92 | 460,578,206.16 | 642,918,508.71 |
| 预付款项 | 440,117,285.4 | 508,155,787.14 | 445,803,941.09 | 514,419,536.14 |
| 其他应收款合计 | 632,928,610.62 | 609,897,223.8 | 517,535,129.39 | 782,158,641.12 |
| 应收股利 | 5,024,474.67 | 223,608.84 | 223,608.84 | 223,608.84 |
| 存货 | 5,030,683,149.6 | 5,327,579,147.01 | 5,535,765,919.86 | 5,200,308,101.69 |
| 一年内到期的非流动资产 | - | 75,464,880.54 | 75,464,880.54 | - |
| 其他流动资产 | 188,965,311.55 | 139,274,907.01 | 222,343,329.23 | 69,370,755.85 |
| 流动资产合计 | 21,614,147,649.45 | 21,804,215,872.95 | 21,227,344,934.47 | 22,720,785,150.72 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,650,742,294.8 | 1,629,415,091.83 | 1,509,122,017.22 | 1,460,238,936.92 |
| 其他权益工具投资 | 674,265,706.81 | 682,132,315.02 | 681,006,253.76 | 667,868,747.53 |
| 投资性房地产 | 10,480,170.79 | 10,694,501.05 | 10,946,776.47 | 11,161,106.73 |
| 固定资产 | 4,289,689,684.93 | 4,389,958,201.12 | 4,470,264,264.88 | 4,223,188,950.66 |
| 在建工程 | 987,615,685.14 | 931,509,517.77 | 832,431,516.18 | 1,085,870,826.31 |
| 使用权资产 | 199,999,619.57 | 158,409,996.23 | 170,395,474.59 | 170,517,205.7 |
| 无形资产 | 3,798,710,511.5 | 3,922,211,412.97 | 3,849,691,624.59 | 3,734,873,742.82 |
| 开发支出 | 2,119,595,539.5 | 1,943,582,627.6 | 1,757,196,902.53 | 1,325,274,459.03 |
| 商誉 | 2,839,831,632.3 | 2,848,210,102.92 | 2,860,135,566.37 | 2,934,647,553.97 |
| 长期待摊费用 | 16,458,438.84 | 18,776,159.14 | 19,541,767.43 | 18,673,755.93 |
| 递延所得税资产 | 439,471,542.07 | 385,084,524.44 | 385,084,524.45 | 256,991,465.54 |
| 其他非流动资产 | 1,334,473,280.11 | 1,183,842,241.9 | 1,264,874,697.98 | 1,318,691,298.62 |
| 非流动资产合计 | 18,361,334,106.36 | 18,103,826,691.99 | 17,810,691,386.45 | 17,207,998,049.76 |
| 资产总计 | 39,975,481,755.81 | 39,908,042,564.94 | 39,038,036,320.92 | 39,928,783,200.48 |
| 流动负债: | | | | |
| 短期借款 | 1,715,030,135.18 | 1,714,508,902.52 | 1,621,903,523.77 | 1,771,270,685.28 |
| 应付票据及应付账款 | 8,312,396,351.72 | 7,609,567,039.98 | 7,969,901,859.1 | 8,770,325,148.97 |
| 其中：应付票据 | 3,068,414,627.61 | 3,017,614,936.17 | 2,910,051,094.08 | 3,675,987,092.13 |
| 应付账款 | 5,243,981,724.11 | 4,591,952,103.81 | 5,059,850,765.02 | 5,094,338,056.84 |
| 预收款项 | 495,915.58 | 502,191.65 | 797,358.84 | 1,273,682.87 |
| 合同负债 | 145,747,142.69 | 232,364,085.08 | 188,554,462.61 | 115,929,823.64 |
| 应付职工薪酬 | 212,037,322.11 | 237,138,507.68 | 411,598,841.94 | 238,395,677.39 |
| 应交税费 | 373,250,286.43 | 553,756,331.7 | 563,317,023.92 | 400,747,695.17 |
| 其他应付款合计 | 2,581,603,873.52 | 2,567,376,516.56 | 2,215,275,211.55 | 3,147,883,822.08 |
| 应付股利 | 101,810,219.6 | 101,810,219.6 | 102,560,219.6 | 125,024,219.6 |
| 一年内到期的非流动负债 | 72,199,920.12 | 82,978,800.49 | 108,871,732.55 | 107,506,993.4 |
| 其他流动负债 | 17,003,618.72 | 34,942,891.8 | 10,443,641.94 | 23,064,901.24 |
| 流动负债合计 | 13,429,764,566.07 | 13,033,135,267.46 | 13,090,663,656.22 | 14,576,398,430.04 |
| 非流动负债: | | | | |
| 长期借款 | 250,096,486.73 | 251,619,962.82 | 252,034,854.55 | 298,867,686.24 |
| 租赁负债 | 116,993,386.72 | 111,057,382.92 | 88,813,504.2 | 100,890,675.57 |
| 长期应付款 | - | - | - | 27,051,665.9 |
| 预计负债 | 4,018,799.32 | 19,922,759.61 | 20,617,015.41 | 31,923,494.11 |
| 递延收益 | 182,119,801.26 | 187,359,036.43 | 190,942,291.61 | 200,612,513.55 |
| 递延所得税负债 | 212,327,829.99 | 217,236,393.17 | 223,959,318.75 | 196,704,637.73 |
| 非流动负债合计 | 765,556,304.02 | 787,195,534.95 | 776,366,984.52 | 856,050,673.1 |
| 负债合计 | 14,195,320,870.09 | 13,820,330,802.41 | 13,867,030,640.74 | 15,432,449,103.14 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,753,736,848 | 1,753,736,848 | 1,753,736,848 | 1,754,021,048 |
| 资本公积 | 2,405,166,419.87 | 2,416,510,921.2 | 2,416,358,618.64 | 2,417,816,815.74 |
| 减:库存股 | - | - | - | 40,768,791.67 |
| 其他综合收益 | -194,461,639.77 | -74,836,933.54 | 5,770,687.07 | 32,763,430.24 |
| 盈余公积 | 1,616,443,486.39 | 1,616,443,486.39 | 1,616,443,486.39 | 1,395,568,477.98 |
| 未分配利润 | 19,860,477,809.2 | 20,021,219,710.05 | 19,019,030,352.89 | 18,573,486,054.02 |
| 归属于母公司股东权益合计 | 25,441,362,923.69 | 25,733,074,032.1 | 24,811,339,992.99 | 24,132,887,034.31 |
| 少数股东权益 | 338,797,962.03 | 354,637,730.43 | 359,665,687.19 | 363,447,063.03 |
| 股东权益合计 | 25,780,160,885.72 | 26,087,711,762.53 | 25,171,005,680.18 | 24,496,334,097.34 |
| 负债和股东权益合计 | 39,975,481,755.81 | 39,908,042,564.94 | 39,038,036,320.92 | 39,928,783,200.48 |
| 公告日期 | 2026-08-27 | 2026-04-24 | 2026-04-24 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |